We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Eitan Medical, a global leader in advanced infusion therapy and drug delivery solutions across the care continuum, announced today that MPP Infusion Centers® (Multispeciality Physician Partners), a Joint
Bausch + Lomb, the eye health business of Bausch Health, has partnered with Lochan to develop the new generation of its eyeTELLIGENCE clinical decision support software. The company
Mindray (SZSE: 300760), a global leading developer and provider of medical devices and solutions, has introduced the Nuewa I9, its latest cart-based ultrasound system and tailored solution for
OraSure Technologies has secured the US Food and Drug Administration (FDA) Emergency Use Authorisation (EUA) for three of its InteliSwab brand rapid antigen tests to detect active Covid-19
Royal Philips (NYSE: PHG, AEX: PHIA), and Elekta (EKTA-B.ST) today signed agreements to deepen their existing strategic partnership to advance comprehensive and personalized cancer care through precision oncology
Guardian Research Network (GRN) today recognized the debut of a groundbreaking multi-cancer early detection (MCED) test called Galleri™. Able to detect more than 50 types of cancers[1] through
Cardiac Insight, Inc., a digital health innovator specializing in wearable cardiac sensors and automated electrocardiogram (ECG) analysis software announced today that it has entered into a distribution agreement
Philips has unveiled positive two-year results from Tack Optimised Balloon Angioplasty (TOBA) II below-the-knee (BTK) clinical trial of its Philips Tack Endovascular System. Tack Endovascular System is a
iHealthScreen has received the CE certification for its AI-based software tool iPredict System for early diagnosis of certain ophthalmic disease types. The iPredict AI Eye Screening System offers
Cytovale, a medical diagnostics company focused on providing a faster, more insightful way to diagnose fast-moving and immune-mediated diseases, today announced the first enrollment in a clinical trial